Clostridium botulinum type C hemagglutinin affects the morphology and viability of cultured mammalian cells via binding to the ganglioside GM3

FEBS Journal

Volumn 282, Issue 17, 2015, Pages 3334-3347

  Sugawara, Yo ^a   Iwamori, Masao ^b   Matsumura, Takuhiro ^a   Yutani, Masahiro ^a   Amatsu, Sho ^a   Fujinaga, Yukako ^a  

^a OSAKA UNIVERSITY   (Japan)

^b KINKI UNIVERSITY   (Japan)

Author keywords

botulinum toxin; ganglioside; GM3; hemagglutinin; sialic acid

Indexed keywords

BACTERIAL PROTEIN; GANGLIOSIDE GM3; GLYCAN; HEMAGGLUTININ; LACTOSYLCERAMIDE; SIALIC ACID; ST I PROTEIN; UNCLASSIFIED DRUG; CADHERIN; PROTEIN BINDING; RECOMBINANT PROTEIN; SIALIC ACID DERIVATIVE; SIALYLTRANSFERASE;

ANIMAL CELL; ARTICLE; BACTERIAL GENE; BINDING KINETICS; CELL CLONE; CELL CULTURE; CELL ISOLATION; CELL STRUCTURE; CELL VIABILITY; CLOSTRIDIUM BOTULINUM TYPE C; CONTROLLED STUDY; FIBROBLAST; LIPOGENESIS; MAMMAL CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENSITIVITY ANALYSIS; ST I GENE; ANIMAL; CARBOHYDRATE ANALYSIS; CELL ADHESION; CELL LINE; CELL PROLIFERATION; CHEMISTRY; CLOSTRIDIUM BOTULINUM; CYTOLOGY; DEFICIENCY; DOG; DRUG EFFECTS; GENE EXPRESSION; GENETICS; MDCK CELL LINE; METABOLISM; MICROARRAY ANALYSIS; MOLECULAR GENETICS;

ANIMALS; BACTERIAL PROTEINS; CADHERINS; CARBOHYDRATE SEQUENCE; CELL ADHESION; CELL LINE; CELL PROLIFERATION; CLOSTRIDIUM BOTULINUM; DOGS; FIBROBLASTS; G(M3) GANGLIOSIDE; GENE EXPRESSION; HEMAGGLUTININS; MADIN DARBY CANINE KIDNEY CELLS; MICE; MICROARRAY ANALYSIS; MOLECULAR SEQUENCE DATA; PROTEIN BINDING; RECOMBINANT PROTEINS; SIALIC ACIDS; SIALYLTRANSFERASES;

EID: 84940688704     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/febs.13346     Document Type: Article

References (44)

1. Rossetto O, Pirazzini M, &, Montecucco C, (2014) Botulinum neurotoxins: genetic, structural and mechanistic insights. Nat Rev Micobiol 12, 535-549.
2. Simpson L, (2013) The life history of a botulinum toxin molecule. Toxicon 68, 40-59.
3. Sakaguchi G, (1982) Clostridium botulinum toxins. Pharmacol Ther 19, 165-194.
4. Oguma K, Inoue K, Fujinaga Y, Yokota K, Watanabe T, Ohyama T, Takeshi K, &, Inoue K, (1999) Structure and function of Clostridium botulinum progenitor toxin. J Toxicol Toxin Rev 18, 17-34.
5. Fujinaga Y, Sugawara Y, &, Matsumura T, (2013) Uptake of botulinum neurotoxin in the intestine. Curr Top Microbiol Immunol 364, 45-59.
6. Fujinaga Y, Inoue K, Watanabe S, Yokota K, Hirai Y, Nagamachi E, &, Oguma K, (1997) The haemagglutinin of Clostridium botulinum type C progenitor toxin plays an essential role in binding of toxin to the epithelial cells of guinea pig small intestine, leading to the efficient absorption of the toxin. Microbiology 143, 3841-3847.
7. Fujinaga Y, Inoue K, Nomura T, Sasaki J, Marvaud JC, Popoff MR, Kozaki S, &, Oguma K, (2000) Identification and characterization of functional subunits of Clostridium botulinum type A progenitor toxin involved in binding to intestinal microvilli and erythrocytes. FEBS Lett 467, 179-183.
8. Kouguchi H, Watanabe T, Sagane Y, Sunagawa H, &, Ohyama T, (2002) In vitro reconstitution of the Clostridium botulinum type D progenitor toxin. J Biol Chem 277, 2650-2656.
9. Arimitsu H, Sakaguchi Y, Lee JC, Ochi S, Tsukamoto K, Yamamoto Y, Ma S, Tsuji T, &, Oguma K, (2008) Molecular properties of each subcomponent in Clostridium botulinum type B haemagglutinin complex. Microb Pathog 45, 142-149.
10. Matsumura T, Jin Y, Kabumoto Y, Takegahara Y, Oguma K, Lencer WI, &, Fujinaga Y, (2008) The HA proteins of botulinum toxin disrupt intestinal epithelial intercellular junctions to increase toxin absorption. Cell Microbiol 10, 355-364.
11. Sugawara Y, Matsumura T, Takegahara Y, Jin Y, Tsukasaki Y, Takeichi M, &, Fujinaga Y, (2010) Botulinum hemagglutinin disrupts the intercellular epithelial barrier by directly binding E-cadherin. J Cell Biol 189, 691-700.
12. Lee K, Zhong X, Gu S, Kruel AM, Dorner MB, Perry K, Rummel A, Dong M, &, Jin R, (2014) Molecular basis for disruption of E-cadherin adhesion by botulinum neurotoxin A complex. Science 344, 1405-1410.
13. Jin Y, Takegahara Y, Sugawara Y, Matsumura T, &, Fujinaga Y, (2009) Disruption of the epithelial barrier by botulinum haemagglutinin (HA) proteins-differences in cell tropism and the mechanism of action between HA proteins of types A or B, and HA proteins of type C. Microbiology 155, 35-45.
14. Yu RK, Tsai YT, Ariga T, &, Yanagisawa M, (2011) Structures, biosynthesis, and functions of gangliosides-an overview. J Oleo Sci 60, 537-544.
15. Jennemann R, &, Gröne HJ, (2013) Cell-specific in vivo functions of glycosphingolipids: lessons from genetic deletions of enzymes involved in glycosphingolipid synthesis. Prog Lipid Res 52, 231-248.
16. Svennerholm L, (1963) Chromatographic separation of human brain gangliosides. J Neurochem 10, 613-623.
17. Simons K, &, Gerl MJ, (2010) Revitalizing membrane rafts: new tools and insights. Nat Rev Mol Cell Biol 11, 688-699.
18. Todeschini AR, &, Hakomori SI, (2008) Functional role of glycoshingolipids and gangliosides in control of cell adhesion, motility, and growth, through glycosynapticmicrodomains. Biochim Biophys Acta 1780, 421-433.
19. Amatsu S, Sugawara Y, Matsumura T, Kitadokoro K, &, Fujinaga Y, (2013) Crystal structure of Clostridium botulinum whole hemagglutinin reveals a huge triskelion-shaped molecular complex. J Biol Chem 288, 35617-35625.
20. FAK accompanies cell adhesion to extracellular matrix: a role in cytoskeletal assembly. J Cell Biol 119, 893-903.
21. Brown MC, &, Turner CE, (2004) Paxillin: adapting to change. Physiol Rev 84, 1315-1339.
22. Inoue K, Sobhany M, Transue TR, Oguma K, Pedersen LC, &, Negishi M, (2003) Structural analysis by X-ray crystallography and calorimetry of a haemagglutinin component (HA1) of the progenitor toxin from Clostridium botulinum. Microbiology 149, 3361-3370.
23. Lee K, Lam KH, Kruel AM, Perry K, Rummel A, &, Jin R, (2014) High-resolution crystal structure of HA33 of botulinum neurotoxin type B progenitor toxin complex. Biochem Biophys Res Commun 446, 568-573.
24. Nakamura T, Tonozuka T, Ide A, Yuzawa T, Oguma K, &, Nishikawa A, (2008) Sugar-binding sites of the HA1 sub-component of Clostridium botulinum type C progenitor toxin. J Mol Biol 376, 854-867.
25. Inoue K, Fujinaga Y, Honke K, Yokota K, Ikeda T, Ohyama T, Takeshi K, Watanabe T, Inoue K, &, Oguma K, (1999) Characterization of haemagglutinin activity of Clostridium botulinum type C and D 16S toxins, and one sub-component of haemagglutinin (HA1). Microbiology 145, 2533-2542.
26. Fujinaga Y, Inoue K, Watarai S, Sakaguchi Y, Arimitsu H, Lee JC, Jin Y, Matsumura T, Kabumoto Y, Watanabe T, et al,. (2004) Molecular characterization of binding sub-components of Clostridium botulinum type C progenitor toxin for intestinal epithelial cells and erythrocytes. Microbiology 150, 1529-1538.
27. Yamashita S, Yoshida H, Uchiyama N, Nakakita Y, Nakakita S, Tonozuka T, Oguma K, Nishikawa A, &, Kamitori S, (2012) Carbohydrate recognition mechanism of HA70 from Clostridium botulinum deduced from X-ray structures in complexes with sialylated oligosaccharides. FEBS Lett 586, 2404-2410.
28. Sugawara Y, Yutani M, Amatsu S, Matsumura T, &, Fujinaga Y, (2014) Functional dissection of the Clostridium botulinum type B hemagglutinin complex: identification of the carbohydrate and E-cadherin binding sites. PLoS One 9, e111170.
29. Lee K, Gu S, Jin L, Le TT, Cheng LW, Strotmeier J, Kruel AM, Yao G, Perry K, Rummel A, et al,. (2013) Structure of a bimodular botulinum neurotoxin complex provides insights into its oral toxicity. PLoS Pathog 9, e1003690.
30. Nishikawa A, Uotsu N, Arimitsu H, Lee JC, Miura Y, Fujinaga Y, Nakada H, Watanabe T, Ohyama T, Sakano Y, et al,. (2004) The receptor and transporter for internalization of Clostridium botulinum type C progenitor toxin into HT-29 cells. Biochem Biophys Res Commun 319, 327-333.
31. Zheng M, Fang H, Tsuruoka T, Tsuji T, Sasaki T, &, Hakomori S, (1993) Regulatory role of GM3 ganglioside in α5β1 integrin receptor for fibronectin-mediated adhesion of FUA169 cells. J Biol Chem 268, 2217-2222.
32. Janich P, &, Corbeil D, (2007) GM1 and GM3 gangliosides highlight distinct lipid microdomains within the apical domain of epithelial cells. FEBS Lett 581, 1783-1787.
33. Chen Y, Qin J, &, Chen ZW, (2008) Fluorescence-topographic NSOM directly visualizes peak-valley polarities of GM1/GM3 rafts in cell membrane fluctuations. J Lipid Res 49, 2268-2275.
34. Hakomori S, Yamamura S, &, Handa AK, (1998) Signal transduction through glyco(sphingo)lipids. Introduction and recent studies on glyco(sphingo)lipid-enriched microdomains. Ann NY Acad Sci 845, 1-10.
35. Fujita A, Cheng J, Hirakawa M, Furukawa K, Kusunoki S, &, Fujimoto T, (2007) Gangliosides GM1 and GM3 in the living cell membrane form clusters susceptible to cholesterol depletion and chilling. Mol Biol Cell 18, 2112-2122.
36. Fujita A, Cheng J, &, Fujimoto T, (2009) Segregation of GM1 and GM3 clusters in the cell membrane depends on the intact actin cytoskeleton. Biochim Biophys Acta 1791, 388-396.
37. Tsukamoto K, Kohda T, Mukamoto M, Takeuchi K, Ihara H, Saito M, &, Kozaki S, (2005) Binding of Clostridium botulinum type C and D neurotoxins to ganglioside and phospholipid. Novel insights into the receptor for clostridial neurotoxins. J Biol Chem 280, 35164-35171.
38. Inui K, Ito H, Miyata K, Matsuo T, Horiuchi R, Ikeda T, Watanabe T, Ohyama T, &, Niwa K, (2010) Involvement of sialic acid in transport of serotype C1 botulinum toxins through rat intestinal epithelial cells. J Vet Med Sci 72, 1251-1255.
39. Nores GA, Dohi T, Taniguchi M, &, Hakomori S, (1987) Density-dependent recognition of cell surface GM3 by a certain anti-melanoma antibody, and GM3 lactone as a possible immunogen: requirements for tumor-associated antigen and immunogen. J Immunol 139, 3171-3176.
40. Daniotti JL, Vilcaes AA, Torres Demichelis V, Ruggiero FM, &, Rodriguez-Walker M, (2013) Glycosylation of glycolipids in cancer: basis for development of novel therapeutic approaches. Front Oncol 19, 306.
41. Krengel U, &, Bousquet PA, (2014) Molecular recognition of gangliosides and their potential for cancer immunotherapies. Front Immunol 5, 325.
42. Kametani Y, &, Takeichi M, (2007) Basal-to-apical cadherin flow at cell junctions. Nat Cell Biol 9, 92-98.
43. Kiguchi K, Iwamori Y, Suzuki N, Kobayashi Y, Ishizuka B, Ishikawa I, Kita T, Kikuchi Y, &, Iwamori M, (2006) Characteristic expression of globotriaosyl ceramide in human ovarian carcinoma-derived cells with anticancer drug resistance. Cancer Sci 97, 1321-1326.
44. McClatchey AI, &, Yap AS, (2012) Contact inhibition (of proliferation) redux. Curr Opin Cell Biol 24, 685-694.